Spaltudaq's Series A Round

Spaltudaq raised a round of funding on November 08, 2004.

Spaltudaq Corporation, a privately-held biotechnology company based in Seattle, is focused on developing therapeutic antibodies for the treatment of inflammation, infectious disease and cancer. Our te…

Articles about Spaltudaq's Series A Round: